Chapter 28. Non pharmacological Prevention of Type 2 Diabetes

  1. Dr Jean-Marie Ekoé Professor of Medicine Faculty of Medicine member recipient principal investigator co-investigator Chairman2,
  2. Dr Marian Rewers principal investigator Core director Program Chair Chair3,
  3. Rhys Williams Dean of Medicine Professor of Clinical Epidemiology chair Vice President Editor-in-Chief member visiting consultant4 and
  4. Paul Zimmet Director Hon. Professor Officer5
  1. Jaakko Tuomilehto

Published Online: 11 SEP 2008

DOI: 10.1002/9780470779750.ch28

The Epidemiology of Diabetes Mellitus, Second Edition

The Epidemiology of Diabetes Mellitus, Second Edition

How to Cite

Tuomilehto, J. (2008) Non pharmacological Prevention of Type 2 Diabetes, in The Epidemiology of Diabetes Mellitus, Second Edition (eds J.-M. Ekoé, M. Rewers, R. Williams and P. Zimmet), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470779750.ch28

Editor Information

  1. 2

    Endocrinologie, Métabolisme et Nutrition, Centre de Recherche du CHUM, Montreal, Canada

  2. 3

    Barbara Davis Center for Childhood Diabetes, University of Colorado School of Medicine, Aurora, CO, USA

  3. 4

    Clinical Epidemiology at the School of Medicine, University of Swansea, Swansea, UK

  4. 5

    International Diabetes Institute Caulfield, Victoria, Australia

Author Information

  1. Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki, Finland

Publication History

  1. Published Online: 11 SEP 2008
  2. Published Print: 19 SEP 2008

ISBN Information

Print ISBN: 9780470017272

Online ISBN: 9780470779750



  • type 2 diabetes - non pharmacological prevention;
  • T2D development and complex multifactorial process;
  • Malmö feasibility study;
  • Da-Qing Study;
  • Indian Diabetes Prevention Program (IDPP);
  • lifetime cost–utility analysis and USD overall cost;
  • Finnish Diabetes Risk Score (FINDRISC);
  • multivariate logistic regression model predicting diabetes


This chapter contains sections titled:

  • Introduction

  • Why Primary Prevention of T2D?

  • Major Lifestyle Trials in Prevention of T2D

  • Long-term Effectiveness of Lifestyle Prevention of T2D

  • Clinical Trial Evidence of the Effect of Lifestyle Factors on T2D Risk

  • Does the Risk Reduction Work in the Entire Population?

  • Costs Associated with Lifestyle Intervention to Prevent T2D

  • Detection of People at High Risk for Developing T2D

  • Conclusion

  • References